News | Simulators | August 01, 2019

Dassault Systèmes, FDA Collaborating on 3-D Living Heart In Silico Clinical Trial

Five-year extension of collaborative research agreement aims to spur medical device innovation by enabling innovative, new product designs through use of 3DEXPERIENCE Platform

Dassault Systèmes, FDA Collaborating on 3-D Living Heart In Silico Clinical Trial

August 1, 2019 — Dassault Systèmes announced the five-year extension of its collaboration with the U.S. Food and Drug Administration (FDA). The 3DEXPERIENCE platform will be used to develop a new digital tool to enable more efficient regulatory review of cardiovascular and medical devices. Researchers hope the process will increase industry innovation and pave the way for an efficient path for patients to access safe, effective new treatments for the world’s leading cause of death – heart disease.

This second phase of their ongoing collaboration supports the 21st Century Cures Act, using virtual patients based on computational modeling and simulation to improve efficiency of clinical trials for new device designs. A groundbreaking project with the Living Heart simulated 3-D heart model will examine the use of heart simulation as a source of digital evidence for new cardiovascular device approvals. This includes an in silico clinical trial aimed to reduce animal testing or the number of patients required while still ensuring safety and efficacy of the device is demonstrated. The new digital process is intended to be more efficient and less expensive than current ones – whose delays and costs can impede patient access to novel treatments – without losing rigor or confidence in a device’s safety and efficacy.

The FDA has publicly recognized the public health benefits offered by modeling and simulation, and the potential for in silico clinical trials to safely advance medical products more efficiently, from preclinical studies through clinical trials to market.

“Modeling and simulation can help to inform clinical trial designs, support evidence of effectiveness, identify the most relevant patients to study and assess product safety. In some cases, in silico clinical trials have already been shown to produce similar results as human clinical trials,” said Tina Morrison, Ph.D., deputy director in the Division of Applied Mechanics, Office of Science and Engineering Labs, Center for Devices and Radiological Health, FDA. “The FDA continues to encourage research to facilitate the introduction of safe and effective therapeutic solutions.”

For more information: www.3ds.com

Related Content

Videos | Advanced Visualization | August 09, 2019
An example of Siemens' photo-realistic Cinematic image reconstruction.
Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug...
Technological Advancements Expected to Drive Virtual Reality Growth in Healthcare
News | Advanced Visualization | April 04, 2019
Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are...
DrChrono and 3D4Medical Partner to Bring 3-D Interactive Modeling to Physician Practices
News | Advanced Visualization | March 18, 2019
DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling...
Philips Introduces IntelliSpace Portal 11 at ECR 2019
Technology | Advanced Visualization | February 27, 2019
Philips announced the launch of IntelliSpace Portal 11, the latest release of the company’s comprehensive, advanced...
Philips and Microsoft have partnered to develop an augmented reality system to help imporve workflow and procedural navigation in the cath lab. Physicians wearing visors can view and interact with true 3-D holograms above the patient on the table and manipulate the image with voice and hand motion commands to avoid breaking the sterile field. Virtual reality in the cath lab, interventional lab, hybrid OR, or cardiovascular lab.

Philips and Microsoft have partnered to develop an augmented reality system to help imporve workflow and procedural navigation in the cath lab. Physicians wearing visors can view and interact with true 3-D holograms above the patient on the table and manipulate the image with voice and hand motion commands to avoid breaking the sterile field. 

News | Advanced Visualization | February 25, 2019
Philips will unveil a new mixed reality concept developed together with Microsoft that the company says is designed for...
Medivis Launches SurgicalAR Augmented Reality Platform
Technology | Advanced Visualization | February 14, 2019
Medical imaging and visualization company Medivis officially unveiled SurgicalAR, its augmented reality (AR) technology...
Videos | Advanced Visualization | December 12, 2018
This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at t
Nihon Kohden Launches Augmented Reality Electrophysiology Training App at HIMSS18
Technology | Advanced Visualization | March 06, 2018
Nihon Kohden announced the launch of the Nihon Kohden Dimensions Augmented Reality (AR) App to complement the Clinical...
Overlay Init